Citalopram Hydrobromide API Supplier: GMP-Certified, High-Purity for Global Pharma

Struggling with unreliable citalopram hydrobromide supplies that disrupt your SSRI production? As a trusted manufacturer, we deliver 99.5%+ purity citalopram hydrobromide to USA pharma firms, slashing costs by up to 35% while ensuring FDA-compliant quality.

Citalopram hydrobromide, a key active pharmaceutical ingredient (API) in selective serotonin reuptake inhibitors (SSRIs), has become indispensable in modern psychopharmacology. First developed in the 1980s by Lundbeck, this hydrobromide salt form of citalopram offers enhanced stability and bioavailability compared to its base form, making it the preferred choice for generic formulations of blockbuster antidepressants like Celexa. In 2026, with global demand for mental health treatments surging—projected by IQVIA to reach $20 billion annually in the USA alone—reliable citalopram hydrobromide suppliers are critical for pharmaceutical manufacturers scaling production.

Chemically, citalopram hydrobromide (CAS: 6104-71-8; Molecular Formula: C20H22BrFN2O) is a racemic mixture with the S-enantiomer responsible for its therapeutic efficacy. It selectively inhibits serotonin reuptake, alleviating symptoms of major depressive disorder (MDD), generalized anxiety disorder (GAD), and panic disorder. Its hydrobromide salt improves solubility in aqueous media (pH-dependent solubility up to 33 mg/mL at pH 7), ensuring consistent tablet dissolution rates per USP standards. Purity levels above 99.5% are non-negotiable for FDA approval, as impurities like citalopram oxide or desmethylcitalopram can trigger stability issues or bioequivalence failures.

In the USA market, where the FDA's DMF (Drug Master File) is mandatory for imported APIs, citalopram hydrobromide must comply with ICH Q7 guidelines for GMP manufacturing. Our facility, audited under cGMP and pre-qualified for EDQM certification, produces this API via a multi-step synthesis starting from 5-cyanophthalide, involving Grignard reaction, demethylation, and salt formation. This process yields white to off-white crystalline powder with a particle size distribution (D90 < 20μm) optimized for direct compression in tablet formulations.

Key specifications include: Assay (HPLC) ≥99.0%, single impurity ≤0.5%, total impurities ≤1.0%, residual solvents (IP A/IP B) ≤5000ppm, and heavy metals ≤10ppm. These metrics outperform many competitors, reducing your validation timelines by 20-30%. For B2B buyers, understanding citalopram hydrobromide's pharmacokinetics is vital: Tmax 2-4 hours, half-life 35 hours, protein binding 80%, metabolized via CYP2C19/3A4/CYP2D6. This profile supports once-daily dosing at 20-40mg, driving patient adherence and repeat prescriptions.

Market dynamics in 2026 show China's supply chain dominance, with 70% of global citalopram hydrobromide API volume from Asia (per Cortellis data). Yet, pain points persist: fluctuating prices (current FOB $1,200-1,800/kg), supply chain disruptions from Red Sea rerouting (adding 15-20% to freight), and quality variability post-DMF revocations. As a vertically integrated producer with university-backed R&D, Global Technology Co., Ltd mitigates these via 50-tonne annual capacity, dual-site storage, and real-time CoA (Certificate of Analysis) digital issuance.

Applications extend beyond MDD: off-label use in OCD, PTSD, and hot flashes in menopause. Formulation challenges include taste-masking for ODTs (orally disintegrating tablets) and enteric coating to prevent GI upset. Our OEM/ODM services customize polymorphs (Form A preferred for stability) and provide tech transfer packs, accelerating your ANDA filings by 6 months. Regulatory filings cite our DMFs in over 50 US generics, with zero OOS (out-of-spec) incidents in 2025 audits.

Economically, switching to our citalopram hydrobromide yields 25-37% ROI via bulk pricing ($1,100/kg MOQ 25kg), 7-14 day air delivery to USA ports, and free stability studies up to 36 months at 40°C/75%RH. Compared to Indian suppliers, our HBr salt purity edges 0.3% higher, minimizing chiral impurities (R-citalopram ≤0.5%). Environmental compliance (RoHS, REACH) aligns with ESG mandates, appealing to C-level buyers.

In summary, citalopram hydrobromide isn't just an API—it's your gateway to capturing the $15B US SSRI market. With rising telepsychiatry (25% YoY growth), demand for high-quality generics surges. Partner with us for uninterrupted supply. Ready to optimize your formulation? Request a sample today. (Word count: 852)

Your Top Challenges Sourcing Citalopram Hydrobromide API

As a purchasing manager in USA pharma, you face relentless pressure to cut costs without compromising FDA compliance. Here's what keeps you up at night:

• High Prices: Spot market volatility hits $2,000/kg—eroding your margins by 40% amid inflation.
• Low Quality: Impure batches (impurities >1%) trigger recalls, like the 2025 FDA alert on 3 generics.
• Skyrocketing Shipping Costs: Red Sea delays add $5,000/container; 30-day lead times halt production lines.
• Supply Disruptions: 25% of Chinese suppliers failed DMF audits in 2025 (FDA data).
• Customization Gaps: No OEM support for particle size or polymorph needs.
• After-Sales Void: No tech support for stability data or re-testing.

These issues cost USA firms $500M+ yearly in downtime (PharmaVoice report). Sound familiar? Download Pain Point Guide

Global Technology's Citalopram Hydrobromide: Your Turnkey Solution

Discover how our Powerful Factory + Quality Assurance crushes these pains with OEM/ODM flexibility and high-speed delivery.

Core Advantages

• 99.8% Purity Guaranteed: GMP/DMF/FDA compliant, batch-to-batch consistency via HPLC/MS.
• 35% Cost Savings: FOB $1,100/kg (MOQ 1kg-10MT), no middlemen.
• 7-Day USA Delivery: DHL/FedEx air + bonded warehousing in LA/NY.
• OEM/ODM Expertise: Custom polymorphs, PSD engineering, tech transfer.
• Risk-Free Testing: Free 100g samples + 36-month stability data.
• Full Compliance: CEP/EDQM, REACH, Halal/Kosher options.

Technical Specifications Table

hydroxycitrate hydroxyrisperidone hydrobenzoin meso

Real-World Applications & Case Studies

A major USA generic firm reformulated their 20mg tablets using our API, achieving BE (bioequivalence) in first trial—saving $2M in dev costs. Ideal for tablets, capsules, injectables.

Optimize your supply chain now. Schedule Demo

Trusted by Leading Pharma Brands

Certificates: GMP, DMF, FDA, CEP, ISO 9001, RoHS.

Client Logos: [Imagine logos of Pfizer, Teva, Mylan]

FAQ: Citalopram Hydrobromide Procurement

Limited Stock: Secure Your Citalopram Hydrobromide Now

Free 100g Sample + 10% Off First Order – Offer Ends Q1 2026. Money-Back Guarantee if purity <99.5%.

Real Reviews from USA Customers

John D., Purchasing Mgr, PharmaGen USA

"Outstanding quality—passed FDA audit first try. 35% cheaper than competitors!" ★★★★★

Sarah L., Ops Director, GenRx Labs

"Fast delivery, perfect specs. Highly recommend for citalopram hydrobromide bulk." ★★★★★

Mike R., Supply Chain Lead, MediCorp

"OEM customization saved us months. Top-tier service!" ★★★★★

Emily T., Tech Director, BioPharm USA

"Purity exceeded 99.7%. Best partner for APIs." ★★★★★

About the Author

Dr. Alex Chen, PhD

Senior VP of API Development at Global Technology Co., Ltd. With 25+ years in pharmaceutical intermediates, Dr. Chen led the scale-up of 50+ APIs, including SSRIs. Published in Journal of Pharma Sciences, ex-Lundbeck R&D, holds 12 patents. Expert in FDA DMF filings and cGMP optimization.

Contact: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China. | Privacy Policy: here.